• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在隔离人群中无症状和有症状 COVID-19 的流行情况。

The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects.

机构信息

Bahrain Defense Force Hospital, Bahrain.

Mohammed bin Khalifa Cardiac Centre, Bahrain.

出版信息

Int J Infect Dis. 2021 Jan;102:285-288. doi: 10.1016/j.ijid.2020.10.091. Epub 2020 Nov 3.

DOI:10.1016/j.ijid.2020.10.091
PMID:33157290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7607262/
Abstract

BACKGROUND

The frequency of asymptomatic SARS-CoV-2 infection with viral spread is unclear. Asymptomatic SARS-CoV-2 infection development and progression was investigated in subjects undergoing mandatory quarantine on airport arrival.

METHODS

2714 subjects were tested for SARS-CoV-2 and all were quarantined for 2 weeks. Viral retesting was undertaken on symptom development and routinely at 14 days if asymptomatic. Asymptomatic, positive patients underwent viral testing every 2 days to determine viral clearance.

RESULTS

188/2714 (6.9%) patients became SARS-CoV-2 positive. On arrival, 136/188 tested positive, with 44/188 (23.4%) symptomatic and 92/188 (48.9%) asymptomatic. All 92 patients remained asymptomatic and were retested every 2 days until viral clearance. 2526 quarantined subjects remained virus free at 14 days. Viral clearance did not differ between symptomatic and asymptomatic patients (12.6 ± 1.0 days and 12.1 ± 0.4 days, respectively). Of the 52/188 (27.7%) testing negative on arrival, 27/52 subsequently became positive and developed symptoms 2-13 days after arrival. 25/188 (13.3%) remained asymptomatic and tested positive at day 14, with viral testing undertaken every 2 days in these subjects; of these, 24 remained asymptomatic, with viral clearance at 9.4 ± 0.7 days - less than for those who were asymptomatic on arrival (p < 0.002).

CONCLUSION

Asymptomatic patients with COVID-19 were more prevalent than those exhibiting symptoms, and are an infection reservoir.

摘要

背景

无症状 SARS-CoV-2 感染的病毒传播频率尚不清楚。本研究旨在调查入境机场强制隔离人群中无症状 SARS-CoV-2 感染的发展和进展。

方法

对 2714 名受试者进行 SARS-CoV-2 检测,所有受试者均被隔离 2 周。出现症状时和无症状时第 14 天常规进行病毒复测。对无症状、阳性患者进行每 2 天 1 次的病毒检测,以确定病毒清除情况。

结果

188/2714(6.9%)例患者 SARS-CoV-2 检测阳性。抵达时,136/188 例检测阳性,其中 44/188(23.4%)例出现症状,92/188(48.9%)例无症状。92 例无症状患者均未出现症状,且在病毒清除前每 2 天检测 1 次。14 天时,2526 例隔离受试者病毒检测均为阴性。症状性和无症状患者的病毒清除时间无差异(分别为 12.6±1.0 天和 12.1±0.4 天)。抵达时检测阴性的 52/188(27.7%)例患者中,27/52 例随后检测阳性,在抵达后第 2-13 天出现症状。188 例患者中有 25/188(13.3%)例无症状且第 14 天检测阳性,这些患者每 2 天进行病毒检测;其中 24 例无症状患者,病毒清除时间为 9.4±0.7 天,短于抵达时无症状患者(p<0.002)。

结论

COVID-19 无症状感染者比有症状感染者更为常见,是感染源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a8/7607262/89d7d90720db/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a8/7607262/89d7d90720db/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a8/7607262/89d7d90720db/gr1_lrg.jpg

相似文献

1
The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects.在隔离人群中无症状和有症状 COVID-19 的流行情况。
Int J Infect Dis. 2021 Jan;102:285-288. doi: 10.1016/j.ijid.2020.10.091. Epub 2020 Nov 3.
2
Silent disease and loss of taste and smell are common manifestations of SARS-COV-2 infection in a quarantine facility: Saudi Arabia.在隔离设施中,无声疾病和味觉及嗅觉丧失是 SARS-CoV-2 感染的常见表现:沙特阿拉伯。
PLoS One. 2020 Oct 30;15(10):e0241258. doi: 10.1371/journal.pone.0241258. eCollection 2020.
3
SARS-CoV-2 Transmission among Marine Recruits during Quarantine.新冠病毒在隔离期间在海军新兵中的传播。
N Engl J Med. 2020 Dec 17;383(25):2407-2416. doi: 10.1056/NEJMoa2029717. Epub 2020 Nov 11.
4
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.无症状SARS-CoV-2感染的高流行率揭示了COVID-19的隐性传播。
Int J Infect Dis. 2021 Apr;105:656-661. doi: 10.1016/j.ijid.2021.02.100. Epub 2021 Feb 26.
5
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
6
Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.2019年冠状病毒病大流行期间航空旅行的常规无症状检测策略:一项模拟研究
Lancet Infect Dis. 2021 Jul;21(7):929-938. doi: 10.1016/S1473-3099(21)00134-1. Epub 2021 Mar 23.
7
The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.美国路易斯安那州社区有症状和无症状 SARS-CoV-2 感染患者出现嗅觉丧失、味觉丧失和年龄的重要性;一项横断面患病率研究。
Clin Microbiol Infect. 2021 Apr;27(4):633.e9-633.e16. doi: 10.1016/j.cmi.2020.12.029. Epub 2021 Jan 6.
8
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率:封锁后时期的监测策略?]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
9
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.韩国社区治疗中心中无症状和有症状的 SARS-CoV-2 感染患者的临床病程和分子病毒脱落情况。
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452. doi: 10.1001/jamainternmed.2020.3862.
10
What was the Prevalence of COVID-19 in Asymptomatic Patients Undergoing Orthopaedic Surgery in One Large United States City Mid-pandemic?大流行期间美国一大型城市行骨科手术的无症状患者中 COVID-19 的患病率是多少?
Clin Orthop Relat Res. 2021 Aug 1;479(8):1691-1699. doi: 10.1097/CORR.0000000000001697.

引用本文的文献

1
A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization.一种基于网络的模型,用于通过贝叶斯优化评估针对新冠疫情的疫苗接种策略。
Chaos Solitons Fractals. 2024 Apr;181. doi: 10.1016/j.chaos.2024.114695. Epub 2024 Mar 14.
2
Impact of a New SARS-CoV-2 Variant on the Population: A Mathematical Modeling Approach.一种新型严重急性呼吸综合征冠状病毒2变体对人群的影响:一种数学建模方法。
Math Comput Appl. 2021 Jun;26(2). doi: 10.3390/mca26020025. Epub 2021 Mar 27.
3
Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects.

本文引用的文献

1
Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.无症状 SARS-CoV-2 感染的流行情况:一项叙述性综述。
Ann Intern Med. 2020 Sep 1;173(5):362-367. doi: 10.7326/M20-3012. Epub 2020 Jun 3.
2
More on COVID-19 coagulopathy in Caucasian patients.关于白种人患者的新型冠状病毒肺炎凝血病的更多信息。
Br J Haematol. 2020 Jun;189(6):1060-1061. doi: 10.1111/bjh.16791. Epub 2020 May 25.
3
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.在一家专业护理机构中出现的 SARS-CoV-2 感染前驱期和传播。
接种疫苗影响下的新冠病毒奥密克戎毒株浪潮的数学建模
Computation (Basel). 2023 Feb;11(2). doi: 10.3390/computation11020036. Epub 2023 Feb 15.
4
A Narrative Review of the Coronavirus Disease 2019 Response in the Kingdom of Bahrain.巴林王国2019年冠状病毒病应对措施的叙述性综述。
Curr Ther Res Clin Exp. 2024 Feb 1;100:100733. doi: 10.1016/j.curtheres.2024.100733. eCollection 2024.
5
Super-spreading social events for COVID-19 transmission: evidence from the investigation of six early clusters in Bahrain.超级传播社交事件在 COVID-19 传播中的作用:来自巴林六个早期聚集性疫情调查的证据。
Front Public Health. 2023 Sep 7;11:1216113. doi: 10.3389/fpubh.2023.1216113. eCollection 2023.
6
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023.2022 年 10 月至 2023 年 1 月期间泰国 SARS-CoV-2 抗核衣壳总 Ig、抗 RBD IgG 抗体和感染的血清流行率:一项横断面调查。
Sci Rep. 2023 Sep 20;13(1):15595. doi: 10.1038/s41598-023-42754-2.
7
Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine.在有和没有SARS-CoV-2感染史且先前已接种两剂BBIBP-CorV加BNT162b2疫苗的医护人员中接种第四剂mRNA-1273后的体液免疫反应。
Vaccines (Basel). 2023 Apr 25;11(5):894. doi: 10.3390/vaccines11050894.
8
Mortality and survival in nonagenarians during the COVID-19 pandemic: Unstable equilibrium of aging.新型冠状病毒肺炎大流行期间九旬老人的死亡率和生存率:衰老的不稳定平衡
Front Med (Lausanne). 2023 Mar 2;10:1132476. doi: 10.3389/fmed.2023.1132476. eCollection 2023.
9
Associations between Coronavirus and Immune Response, Cardiorespiratory Fitness Rehabilitation and Physical Activity: A Brief Report.冠状病毒与免疫反应、心肺功能康复和体力活动的关联:简要报告。
Int J Environ Res Public Health. 2023 Mar 6;20(5):4651. doi: 10.3390/ijerph20054651.
10
Prevalence of Anti-SARS-CoV-2 Antibodies and Associated Factors Among Health Care Workers in Santiago De Cali, Colombia.哥伦比亚卡利市圣地亚哥医护人员中抗SARS-CoV-2抗体的流行率及相关因素
Int J Gen Med. 2023 Feb 23;16:697-705. doi: 10.2147/IJGM.S396357. eCollection 2023.
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
4
Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy.意大利 COVID-19 疫情期间三级急救转诊中心的医院扩充能力。
Anaesthesia. 2020 Jul;75(7):928-934. doi: 10.1111/anae.15072. Epub 2020 Apr 22.
5
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.估算 2020 年日本横滨钻石公主号游轮上的 2019 年冠状病毒病(COVID-19)病例的无症状比例。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180.
6
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).新型冠状病毒感染(COVID-19)无症状感染率的估计。
Int J Infect Dis. 2020 May;94:154-155. doi: 10.1016/j.ijid.2020.03.020. Epub 2020 Mar 14.
7
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.新型冠状病毒肺炎(COVID-19)的潜伏期来自公开报告的确诊病例:估计和应用。
Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.
8
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.通过隔离病例和接触者控制 COVID-19 疫情爆发的可行性。
Lancet Glob Health. 2020 Apr;8(4):e488-e496. doi: 10.1016/S2214-109X(20)30074-7. Epub 2020 Feb 28.
9
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病(COVID-19)疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
10
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.感染患者上呼吸道标本中的新型冠状病毒2型病毒载量
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.